CLINICAL_TRIALS
research
· 2024-07-30
Clinical Trial Update: Impact of Smoking on Salivary Interleukin (IL)-39, IL-41, IL-1β, TNF-α Levels in Periodontal Disease
Summary
Clinical trial investigating how smoking affects salivary inflammatory biomarkers (IL-39, IL-41, IL-1β, TNF-α) in periodontitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Necmettin Erbakan University | Conditions: Periodontitis, Adult, Smoking | Status: NOT_YET_RECRUITING